These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 15161024)
1. Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines. Weber B; Serafin A; Michie J; Van Rensburg C; Swarts JC; Bohm L Anticancer Res; 2004; 24(2B):763-70. PubMed ID: 15161024 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of CHO cells by two novel rhodium complexes under oxic and hypoxic conditions. Falzone N; Böhm L; Swarts JC; Van Rensburg CE Anticancer Res; 2006; 26(1A):147-52. PubMed ID: 16475691 [TBL] [Abstract][Full Text] [Related]
3. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells. O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961 [TBL] [Abstract][Full Text] [Related]
4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity. Michie J; Akudugu J; Binder A; Van Rensburg CE; Böhm L Anticancer Res; 2003; 23(3B):2675-9. PubMed ID: 12894557 [TBL] [Abstract][Full Text] [Related]
6. Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines. Serafin AM; Bohm L Urol Oncol; 2005; 23(2):123-9. PubMed ID: 15869997 [TBL] [Abstract][Full Text] [Related]
7. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
8. Relationship between electrochemical potentials and substitution reaction rates of ferrocene-containing β-diketonato rhodium(I) complexes; cytotoxicity of [Rh(FcCOCHCOPh)(cod)]. Conradie J; Swarts JC Dalton Trans; 2011 Jun; 40(22):5844-51. PubMed ID: 21423964 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells. Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS(3). Bieda R; Ott I; Dobroschke M; Prokop A; Gust R; Sheldrick WS J Inorg Biochem; 2009 May; 103(5):698-708. PubMed ID: 19243835 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706 [TBL] [Abstract][Full Text] [Related]
12. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin. Boersma AW; Nooter K; Oostrum RG; Stoter G Cytometry; 1996 Jun; 24(2):123-30. PubMed ID: 8725661 [TBL] [Abstract][Full Text] [Related]
13. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific. Kissel CK; Schadendorf D; Röckmann H Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1. Chauhan P; Sodhi A; Tarang S Anticancer Drugs; 2007 Feb; 18(2):187-96. PubMed ID: 17159605 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner. Wu XX; Kakehi Y Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256 [TBL] [Abstract][Full Text] [Related]
16. Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells. Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA Eur J Pharmacol; 2007 Aug; 569(1-2):16-28. PubMed ID: 17585902 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R Anticancer Res; 2005; 25(1A):139-47. PubMed ID: 15816531 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis. Koshibu-Koizumi J; Akazawa M; Iwamoto T; Takasaki M; Mizuno F; Kobayashi R; Abe A; Tomoda A; Hamatake M; Ishida R J Cancer Res Clin Oncol; 2002 Jul; 128(7):363-8. PubMed ID: 12136250 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of necrosis in C2-ceramide-induced cytotoxicity in NB16 neuroblastoma cells. Ramos B; Lahti JM; Claro E; Jackowski S Mol Pharmacol; 2003 Aug; 64(2):502-11. PubMed ID: 12869656 [TBL] [Abstract][Full Text] [Related]
20. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]